Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Fatty Liver
A pilot trial exploring the role of gut microbiota in fatty liver has been withdrawn. The study identifier is NCT04160949 and sponsor is Pro…
-
EMA withdrawal · 2022-04-08EMA Application withdrawn: Zektayos - Hepjuvo (obeticholic acid) — Advanz Pharma Limited
The EMA has withdrawn the application for Zektayos - Hepjuvo (obeticholic acid) by Advanz Pharma Limited for fatty liver disease.